PriceTargets.com logo

BELLUS Health - BLU Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00 As of 06/30/2023 12:59 AM ET
+0 (0.00%)

This chart shows the closing price for BLU by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BELLUS Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BLU and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BLU

Analyst Price Target is C$0.00
This price target is based on 0 analysts offering 12 month price targets for BELLUS Health in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.

This chart shows the closing price for BLU for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in BELLUS Health. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/1/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/31/2026

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/18/2023Lifesci CapitalDowngradeOutperform ➝ Market Perform
11/15/2022EvercoreReiterated RatingBuyC$24.00
7/12/2022HC WainwrightReiterated RatingBuyC$16.00
5/12/2022HC WainwrightReiterated RatingBuyC$16.00
2/24/2022HC WainwrightReiterated RatingBuyC$16.00
12/17/2021Royal Bank Of CanadaBoost TargetOutperformC$11.00 ➝ C$14.00
12/13/2021BTIG ResearchInitiated CoverageBuyC$18.00
12/13/2021TD CowenReiterated RatingBuyC$15.00
11/15/2021BTIG ResearchReiterated RatingBuyC$13.00
11/12/2021HC WainwrightReiterated RatingBuyC$14.00
9/23/2021BTIG ResearchReiterated RatingBuyC$13.00
9/14/2021HC WainwrightReiterated RatingBuyC$14.00
9/13/2021BTIG ResearchInitiated CoverageBuyC$13.00
8/13/2021Bloom BurtonReiterated RatingBuy
8/12/2021Royal Bank Of CanadaReiterated RatingOutperformC$8.00
(Data available from 7/31/2021 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/2/2026
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/1/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/3/2026
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/2/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/2/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/1/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/1/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/31/2026

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
BELLUS Health logo
BluEnergies Ltd. is a Canadian based oil and gas exploration and development company focused on offshore West Africa. The Company has recently partnered with TotalEnergies to explore its basin floor fan plays in Blocks LB-26, LB-30, and LB-31 covering an area of approximately 8,924 square kilometers (~2.2 million acres) located in the Harper Basin, in the deep-water offshore Liberia. Additionally, the Company recently acquired a previously discovered and tested sand channel play offshore Louisiana in the shallow water Gulf of America.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

28,666 shs

Average Volume

59,471 shs

Market Capitalization

C$2.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of BELLUS Health?

The following equities research analysts have issued reports on BELLUS Health in the last twelve months:
View the latest analyst ratings for BLU.

What is the current price target for BELLUS Health?

0 Wall Street analysts have set twelve-month price targets for BELLUS Health in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for BELLUS Health in the next year.
View the latest price targets for BLU.

What is the current consensus analyst rating for BELLUS Health?

BELLUS Health currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BLU.

What other companies compete with BELLUS Health?

Other companies that are similar to BELLUS Health include Trillium Therapeutics, Oncolytics Biotech, Concordia International, Fennec Pharmaceuticals and ProMetic Life Sciences. Learn More about companies similar to BELLUS Health.

How do I contact BELLUS Health's investor relations team?

BELLUS Health's physical mailing address is 9-275 Armand-Frappier Blvd, LAVAL, QC H7V 4A7, Canada. The company's listed phone number is +1-450-6804500. The official website for BELLUS Health is www.bellushealth.com. Learn More about contacing BELLUS Health investor relations.